To determine if these differential peaks sufficiently distinguish between samples from breast cancer patients and healthy donors, we compiled a peak list containing all differentially enriched regions from both T47D and CD4+ T cells (2804 genomic regions, Supplementary Data 1). This evidence concerns the gene CD4 and breast cancer.